High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer.
Ulrich BickChristoph EngelBarbara KrugWalter HeindelEva M FallenbergKerstin RhiemDavid MaintzMichael GolattaDorothee SpeiserDorothea Rjosk-DendorferIrina Lämmer-SkarkeFrederic DietzelKarl Werner Fritz SchäferElena LeinertStefanie WeigelStephanie SauerStefanie PertschyThomas HofmockelAnne Hagert-WinklerKarin KastAnne QuanteAlfons MeindlMarion KiechleMarkus LoefflerRita K Schmutzlernull nullPublished in: Breast cancer research and treatment (2019)
High-risk screening with MRI was successfully implemented in the GC-HBOC with high sensitivity and specificity. Risk prediction and inclusion criteria in high-risk non-carriers need to be adjusted to improve CDRs and thus screening efficacy in these patients.